CVE-2023-38956

7.5 highEPSS 0.7%

High (7.5) in zkteco bioaccess ivs. EPSS 0.7% chance of exploitation in the next 30 days.

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

Severity

CVSS 3.1

7.5 high

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

EPSS: 0.7% chance of exploitation in the next 30 days; higher than 54% of CVEs (scores of 2026-11-01)
CWE: CWE-22
Published: 2023-08-03
Modified: 2026-07-09
Record from: the NVD, synced 2026-10-19

Affected

zkteco:bioaccess_ivs

References

https://claroty.com/team82/disclosure-dashboard/cve-2023-38956
https://claroty.com/team82/disclosure-dashboard/cve-2023-38956

Check your stack JSON